Half-year report · Q2

Period2025-01-01 → 2025-06-30
Filed2025-08-08
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
MetricValuePeriodScopeSource row
Revenue¥46.1bn2025-01-01 → 2025-06-30Cons.Net sales
Revenue¥67.5bn2024-01-01 → 2024-12-31Cons.Net sales (5-year summary)
Revenue¥24.3bn2024-01-01 → 2024-06-30Cons.Net sales
Operating income¥2.1bn2025-01-01 → 2025-06-30Cons.Operating income
Operating income¥983m2024-01-01 → 2024-06-30Cons.Operating income
Ordinary income¥2.3bn2025-01-01 → 2025-06-30Cons.Ordinary income
Ordinary income¥2.6bn2024-01-01 → 2024-12-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥971m2024-01-01 → 2024-06-30Cons.Ordinary income
Profit before tax¥3.9bn2025-01-01 → 2025-06-30Cons.Income before income taxes
Profit before tax¥921m2024-01-01 → 2024-06-30Cons.Income before income taxes
Net income (owners)¥2.5bn2025-01-01 → 2025-06-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥6.3bn2024-01-01 → 2024-12-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥577m2024-01-01 → 2024-06-30Cons.Profit loss attributable to owners of parent
Net income¥2.7bn2025-01-01 → 2025-06-30Cons.Profit loss
Net income¥588m2024-01-01 → 2024-06-30Cons.Profit loss
Total assets¥51.0bnat 2025-06-30Cons.Assets
Total assets¥63.2bnat 2024-12-31Cons.Assets
Total assets¥44.4bnat 2024-06-30Cons.Total assets (5-year summary)
Total liabilities¥21.6bnat 2025-06-30Cons.Liabilities
Total liabilities¥35.8bnat 2024-12-31Cons.Liabilities
Net assets / equity¥29.4bnat 2025-06-30Cons.Net assets
Net assets / equity¥27.4bnat 2024-12-31Cons.Net assets
Net assets / equity¥20.5bnat 2024-06-30Cons.Net assets (5-year summary)
Cash and deposits¥5.3bnat 2025-06-30Cons.Cash and deposits
Cash and deposits¥4.1bnat 2024-12-31Cons.Cash and deposits
Cash & equivalents¥5.2bnat 2025-06-30Cons.Cash and cash equivalents
Cash & equivalents¥4.1bnat 2024-12-31Cons.Cash and cash equivalents
Cash & equivalents¥6.1bnat 2024-06-30Cons.Cash and cash equivalents
Cash & equivalents¥1.7bnat 2023-12-31vCons.Cash and cash equivalents
Operating cash flow¥2.2bn2025-01-01 → 2025-06-30Cons.Net cash provided by used in operating activities
Operating cash flow¥6.2bn2024-01-01 → 2024-12-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥3.6bn2024-01-01 → 2024-06-30Cons.Net cash provided by used in operating activities
Investing cash flow¥13.9bn2025-01-01 → 2025-06-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥4.1bn2024-01-01 → 2024-12-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥959m2024-01-01 → 2024-06-30Cons.Net cash provided by used in investment activities
Financing cash flow−¥15.0bn2025-01-01 → 2025-06-30Cons.Net cash provided by used in financing activities
Financing cash flow¥376m2024-01-01 → 2024-12-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow¥1.8bn2024-01-01 → 2024-06-30Cons.Net cash provided by used in financing activities
EPS (basic)¥49.342025-01-01 → 2025-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥125.342024-01-01 → 2024-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥11.552024-01-01 → 2024-06-30Cons.Basic earnings loss per share (5-year summary)
Equity ratio54.7%at 2025-06-30Cons.Equity to asset ratio (5-year summary)
Equity ratio41.3%at 2024-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio46.0%at 2024-06-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 19
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2025-01-01 → 2025-06-30−¥78m
Reconciling Itemsreconcilingrevenue intersegment2025-01-01 → 2025-06-30−¥78m
Reconciling Itemsreconcilingsegment profit2025-01-01 → 2025-06-30−¥7m
jpcrp040300-q2r_E32453-000Cimedical Businessreportable segmentrevenue2025-01-01 → 2025-06-30¥26.1bn
jpcrp040300-q2r_E32453-000Cimedical Businessreportable segmentrevenue external2025-01-01 → 2025-06-30¥26.0bn
jpcrp040300-q2r_E32453-000Cimedical Businessreportable segmentrevenue intersegment2025-01-01 → 2025-06-30¥51m
jpcrp040300-q2r_E32453-000Cimedical Businessreportable segmentsegment profit2025-01-01 → 2025-06-30¥1.9bn
jpcrp040300-q2r_E32453-000Nissen Businessreportable segmentrevenue2025-01-01 → 2025-06-30¥17.1bn
jpcrp040300-q2r_E32453-000Nissen Businessreportable segmentrevenue external2025-01-01 → 2025-06-30¥17.1bn
jpcrp040300-q2r_E32453-000Nissen Businessreportable segmentrevenue intersegment2025-01-01 → 2025-06-30¥11m
jpcrp040300-q2r_E32453-000Nissen Businessreportable segmentsegment profit2025-01-01 → 2025-06-30¥252m
jpcrp040300-q2r_E32453-000Shirohato Businessreportable segmentrevenue2025-01-01 → 2025-06-30¥3.1bn
jpcrp040300-q2r_E32453-000Shirohato Businessreportable segmentrevenue external2025-01-01 → 2025-06-30¥3.1bn
jpcrp040300-q2r_E32453-000Shirohato Businessreportable segmentrevenue intersegment2025-01-01 → 2025-06-30¥15m
jpcrp040300-q2r_E32453-000Shirohato Businessreportable segmentsegment profit2025-01-01 → 2025-06-30¥20m
—segment totalrevenue2025-01-01 → 2025-06-30¥46.2bn
—segment totalrevenue external2025-01-01 → 2025-06-30¥46.1bn
—segment totalrevenue intersegment2025-01-01 → 2025-06-30¥78m
—segment totalsegment profit2025-01-01 → 2025-06-30¥2.1bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 515
ItemContextValueUnit
Loss on reduction of noncurrent assets ope cfPrior1YTDDuration-JPY
Loss on reduction of noncurrent assets ope cfCurrentYTDDuration11518000000JPY
Loss gain on redemption of investment securities ope cfPrior1YTDDuration51000000JPY
Loss gain on redemption of investment securities ope cfCurrentYTDDuration23000000JPY
Impairment loss ope cfPrior1YTDDuration-JPY
Impairment loss ope cfCurrentYTDDuration189000000JPY
Decrease increase in notes and accounts receivable trade ope cfPrior1YTDDuration-279000000JPY
Decrease increase in notes and accounts receivable trade ope cfCurrentYTDDuration217000000JPY
Decrease increase in inventories ope cfPrior1YTDDuration-40000000JPY
Decrease increase in inventories ope cfCurrentYTDDuration324000000JPY
Decrease increase in other assets ope cfPrior1YTDDuration1737000000JPY
Decrease increase in other assets ope cfCurrentYTDDuration47000000JPY
Increase decrease in notes and accounts payable trade ope cfPrior1YTDDuration106000000JPY
Increase decrease in notes and accounts payable trade ope cfCurrentYTDDuration-134000000JPY
Increase decrease in other liabilities ope cfPrior1YTDDuration384000000JPY
Increase decrease in other liabilities ope cfCurrentYTDDuration-1071000000JPY
Subtotal ope cfPrior1YTDDuration4018000000JPY
Subtotal ope cfCurrentYTDDuration2447000000JPY
Interest and dividends income received ope cf inv cfPrior1YTDDuration32000000JPY
Interest and dividends income received ope cf inv cfCurrentYTDDuration37000000JPY
Interest expenses paid ope cf fin cfPrior1YTDDuration-23000000JPY
Interest expenses paid ope cf fin cfCurrentYTDDuration-51000000JPY
Income taxes paid ope cfPrior1YTDDuration-396000000JPY
Income taxes paid ope cfCurrentYTDDuration-252000000JPY
Net cash provided by used in operating activitiesPrior1YTDDuration3631000000JPY
Net cash provided by used in operating activitiesCurrentYTDDuration2179000000JPY
Payments into time deposits inv cfPrior1YTDDuration-JPY
Payments into time deposits inv cfCurrentYTDDuration-31000000JPY
Purchase of property plant and equipment and intangible assets inv cfPrior1YTDDuration-999000000JPY
Purchase of property plant and equipment and intangible assets inv cfCurrentYTDDuration-345000000JPY
Proceeds from sales of property plant and equipment and intangible assets inv cfPrior1YTDDuration35000000JPY
Proceeds from sales of property plant and equipment and intangible assets inv cfCurrentYTDDuration1281000000JPY
Purchase of investment securities inv cfPrior1YTDDuration-107000000JPY
Purchase of investment securities inv cfCurrentYTDDuration-84000000JPY
Proceeds from sales and redemption of investment securities inv cfPrior1YTDDuration109000000JPY
Proceeds from sales and redemption of investment securities inv cfCurrentYTDDuration95000000JPY
Subsidies received inv cfPrior1YTDDuration-JPY
Subsidies received inv cfCurrentYTDDuration13036000000JPY
Payments for asset retirement obligations inv cfPrior1YTDDuration-JPY
Payments for asset retirement obligations inv cfCurrentYTDDuration-19000000JPY
Other net inv cfPrior1YTDDuration2000000JPY
Other net inv cfCurrentYTDDuration-22000000JPY
Net cash provided by used in investment activitiesPrior1YTDDuration-959000000JPY
Net cash provided by used in investment activitiesCurrentYTDDuration13910000000JPY
Net increase decrease in short term loans payable fin cfPrior1YTDDuration2000000000JPY
Net increase decrease in short term loans payable fin cfCurrentYTDDuration-18000000000JPY
Proceeds from long term loans payable fin cfPrior1YTDDuration30000000JPY
Proceeds from long term loans payable fin cfCurrentYTDDuration6061000000JPY
Repayment of long term loans payable fin cfPrior1YTDDuration-17000000JPY
Repayment of long term loans payable fin cfCurrentYTDDuration-2352000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2024-12-31pass
balance sheet identityconsolidated 2025-06-30pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2024-12-31pass
statement vs summary · net assetsconsolidated 2025-06-30pass
statement vs summary · net income attributable to parentconsolidated 2024-01-01/2024-06-30pass
statement vs summary · net income attributable to parentconsolidated 2025-01-01/2025-06-30pass
statement vs summary · operating cash flowconsolidated 2024-01-01/2024-06-30pass
statement vs summary · operating cash flowconsolidated 2025-01-01/2025-06-30pass
statement vs summary · revenueconsolidated 2024-01-01/2024-06-30pass
statement vs summary · revenueconsolidated 2025-01-01/2025-06-30pass
statement vs summary · total assetsconsolidated 2024-12-31pass
statement vs summary · total assetsconsolidated 2025-06-30pass